Discuss the financial return on investment recognized by operating a comprehensive medication review (CMR) program for commercially-insured patients.
List strategic areas of focus for CMR programs designed to benefit commercially-insured patients.
Describe the steps necessary to design a CMR program targeted to the initiatives important to participants' own organizations.
Session Description: CMRs have garnered significant attention for their role in enhancing patient outcomes and mitigating healthcare expenditures within Medicare. However, their impact on fully insured populations in the ACA marketplace remains a topic of substantial interest and investigation.
Through rigorous analysis, we seek to answer whether patients, under the purview of fully insured plans, experience improved health outcomes as a direct correlation to CMRs. To do so, we identify the critical outcomes of interest, providing attendees with a nuanced understanding of the specific health metrics that come into play.
Furthermore, our research delves into the realm of patient engagement, a crucial aspect of modern healthcare. We evaluated whether CMRs have the potential to enhance patient engagement, fostering a more dynamic and proactive relationship between patients and their healthcare providers. In doing so, we explore the broader implications of CMRs in the context of a fully insured ACA marketplace, setting the stage for a thought-provoking discussion on the future of healthcare delivery and cost containment.
Join us in this engaging session to gain valuable insight into the world of healthcare economics, as we uncover the potential of CMRs in improving patient outcomes, reducing healthcare costs, and revolutionizing patient engagement within the ACA marketplace.
.jpg "Meridith Dandridge, PharmD, BCGP photo")
.jpg "Ross M. Frei, MBA photo")